We use cookies for a better user experience. Read our Privacy Policy

I Agree

Oral Thin Films Market

Oral Thin Films Market (Product: Sublingual Film, Fast-dissolving Oral Film, and Buccal Film) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Oral Thin Films Market Outlook 2031

  • The industry was valued at US$ 2.9 Bn in 2021
  • It is projected to grow at a CAGR of 9.3% from 2022 to 2031 and reach more than US$ 7.1 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

Growth in investment in R&D of fast-dissolving oral films and rise in demand for thin-film drug delivery systems are driving the oral thin films market size.

Demand for Oral Thin Films (OTFs) is high due to their ability to incorporate even poorly soluble drugs. Rise in adoption of patient-friendly drug delivery systems is expected to augment market expansion during the forecast period.

OTFs can be wetted, dissolved, and disintegrated much more quickly than other drug delivery methods due to their significantly larger surface area. They can also be made to have a pleasing color and flavor in order to appeal to young children.

Market vendors are investing significantly in pre-development, formulation, and clinical supply manufacturing of new products to increase their oral thin films market share.

Oral Thin Films Market

Market Introduction

The pharmaceutical industry is seeking new ways to deliver drugs using thin films. OTFs are very thin films made of a mono or multi-layer polymeric matrix. They are often water-based, soluble polymers that are intended for rapid drug delivery. Thin films are an alternative to conventional dosage forms. They are flexible systems that offer immediate, regional, or systemic effects.

The oral thin-film technology is simple to use and beneficial for patients who have difficulty swallowing and/or are young, elderly, or bedridden. These drug delivery systems can be administered orally, buccally, sublingually, ocularly, and transdermally.

OTFs can be termed ‘precision medication,’ as they have perforations in a single film that provide accurate and flexible dosing. They are ideal for children who need smaller and more variable doses. Adults who want to take partial doses of medication can also rely on oral thin films.

Various studies are investigating capable new particle engineering techniques to discover innovative ways to increase the solubility of water-insoluble drugs in OTFs.

However, OTFs can only transport a relatively small drug load of 10 to 20 mgs. Future research can help establish OTFs as a common dosage form for all pharmaceuticals.

Request a sample to get extensive insights into the Oral Thin Films Market

Growth in Investment in R&D of Fast-dissolving Oral Films Driving Oral Thin Films Market Statistics

Fast-dissolving oral film is the latest advanced oral solid dosage form. It offers greater flexibility and comfort. Fast-dissolving oral films improve API effectiveness by dissolving in the oral cavity within minutes after contact with saliva without chewing.

Fast-dissolving oral films do not require water for administration. These drugs are absorbed quickly and have instant bioavailability due to the high blood flow and absorption of the oral mucosa. These benefits are likely to propel the oral thin films business growth in the next few years.

Oral route is the most efficient option for drug delivery. However, it is often inconvenient for elderly and pediatric patients. Orally disintegrating films have demonstrated effectiveness in distributing quick drug action by dissolving the drug in the buccal cavity.

Over the last decade, oral thin films have grown in marketable importance in both generic and non-generic markets. Researchers are constantly seeking new strategies to create advanced, modern dosage designs that are not only safe and effective but also savvy and simple to deliver.

The final form of OTFs allows for quick production with the development of aqueous-based film manufacturing that does not require solvents. This process is efficient, as it requires just two steps of combining, followed by casting, while producing tablets and capsules is far more complicated.

Rise in Adoption of Patient-friendly Drug Delivery Systems

Drugs delivered via OTFs are helpful for people who have difficulty swallowing, such as young children, the elderly, and people who experience nausea. Thus, more medications for a wider range of disease indications are likely to be converted to oral thin films in the near future. Rise in geriatric population is also projected to augment oral thin films market progress in the next few years.

Oral fast-dissolving film is a cutting-edge, patient-friendly, and inventive delivery method. This innovative dosage form is gaining traction due to several benefits, including rapid dissolution without the use of water and high compliance with both geriatric and pediatric patients in urgent situations and specific diseases. It is also a beneficial dosage form for a drug, which has lower bioavailability and pre-systemic metabolism.

OTFs have a much larger surface area than other drug delivery methods. This allows for faster disintegration, wetting, and dissolution. OTFs can have a pleasing flavor and color, making them suitable for young children.

Request a custom report on Oral Thin Films Market

High Adoption of Sublingual Thin Films

According to the latest oral thin films market in-depth analysis, the sublingual film product segment held significant share in 2021. Thin membrane structure and high level of vascularization of sublingual mucosa result in a high membrane permeability. Sublingual mucosa offers very good bioavailability. Better permeability can be ascribed to increased blood flow and lymphatic circulation, which skips the first-pass effect and results in increased systemic bioavailability.

Drugs are administered sublingually by placing them under the tongue. The sublingual route avoids first-pass metabolism, which accelerates the drug's entry into the systemic circulation. The drug directly enters the systemic circulation using blood vessels. Significant research activities, a strong product pipeline, and high adoption of sublingual films are driving the segment.

Increase in Prevalence of Neurosurgical Disorders

The neurosurgical disorder indication segment is expected to dominate the oral thin films market during the forecast period. Growth of the segment can be ascribed to high prevalence of neurological disorders across the globe. Neurological disorders are the third leading cause of disability and premature death in the European Union.

Oral thin films are ideal for therapies requiring rapid drug absorption, such as pain, allergies, sleep disorders, and disorders of the nervous system.

Surge in Number of Retail Pharmacies  

The retail pharmacies distribution channel segment is projected to account for major share of the global oral thin films market during the forecast period. High preference for retail pharmacies, easy availability of a wide range of products and home delivery, and increase in number of retail pharmacies in developing countries are boosting the segment.

The online pharmacies segment is likely to be driven by expansion in the e-commerce sector and rise in convenience in choosing a wide range of oral thin film products.

Regional Outlook of Oral Thin Films Market

North America is anticipated to dominate the business during the forecast period. Increase in investment in R&D activities and rise in approval and launch of new oral thin films are fueling the market share of the region.

The industry in Asia Pacific is expected to grow at a significant pace during 2022 to 2031. High presence of local and global oral thin film manufacturers, increase in geriatric population, and surge in healthcare expenditure are propelling market development in the region.

Analysis of Key Players in Global Oral Thin Films Industry

The market is home to a small number of dominant players. The oral thin films market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments. Most of the firms are adopting M&A, product development and launch, collaboration, and partnership strategies to increase their revenue share.

Aquestive Therapeutics, Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy's Laboratories, Indivior plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co., Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co., Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals, Inc., and ZIM Laboratories Limited are key entities operating in this industry.

Key Developments

  • In October 2022, IntelGenx Corp. announced the start of the first-in-human clinical study of an oral thin film psychedelic drug candidate in collaboration with Atai Life Sciences
  • In July 2021, ZIM Laboratories announced that Infarmed had authorized the marketing of Rizatriptan Orally Dissolving Film to its wholly-owned European subsidiary in Portugal

Oral Thin Films Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 2.9 Bn

Market Forecast Value in 2031

More than US$ 7.1 Bn

Growth Rate (CAGR)

9.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis and regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Sublingual Film
    • Fast-dissolving Oral Film
    • Buccal Film
  • Indication
    • Pain Management
    • Neurological Disorders
    • Nausea & Vomiting
    • Opioid Dependence
    • Others
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries

Companies Profiled

  • Aquestive Therapeutics, Inc.
  • C.L. Pharm
  • Cure Pharmaceutical
  • Dr. Reddy's Laboratories
  • Indivior plc
  • IntelGenx Corp.
  • Kyu Kyu Pharmaceutical Co., Ltd.
  • DK Livkon Pvt. Ltd.
  • NAL Pharma
  • Seoul Pharma Co., Ltd.
  • Shilpa Therapeutics Pvt. Ltd.
  • Sunovion Pharmaceuticals Inc.
  • ZIM Laboratories Limited

Customization Scope

Available upon request

Pricing

Available upon request

Oral Thin Films Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global oral thin films market in 2021?

It was valued at US$ 2.9 Bn in 2021.

How big will the industry be in 2031?

It is projected to reach more than US$ 7.1 Bn by 2031.

What will be the CAGR during the forecast period?

It is anticipated to be 9.3% from 2022 to 2031.

Which prominent trends affect business growth?

Investment in R&D of fast-dissolving oral films and rise in demand for thin-film drug delivery systems.

Which region will account for major share during the forecast period?

North America is expected to account for major share from 2022 to 2031.

Who are the prominent players operating in the sector?

Aquestive Therapeutics, Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy's Laboratories, Indivior plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co., Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co., Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals, Inc., and ZIM Laboratories Limited.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oral Thin Films Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Oral Thin Films Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

    5.5. Insights on Development of Advanced Drug Delivery Systems

6. Global Oral Thin Films Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Sublingual Film

        6.3.2. Fast-dissolving Oral Film

        6.3.3. Buccal Film

    6.4. Market Attractiveness Analysis, by Product

7. Global Oral Thin Films Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Indication, 2017–2031

        7.3.1. Pain Management

        7.3.2. Neurological Disorders

        7.3.3. Nausea & Vomiting

        7.3.4. Opioid Dependence

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Indication

8. Global Oral Thin Films Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Distribution Channel, 2017–2031

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Oral Thin Films Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017–2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Oral Thin Films Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Sublingual Film

        10.2.2. Fast-dissolving Oral Film

        10.2.3. Buccal Film

    10.3. Market Value Forecast, by Indication, 2017–2031

        10.3.1. Pain Management

        10.3.2. Neurological Disorders

        10.3.3. Nausea & Vomiting

        10.3.4. Opioid Dependence

        10.3.5. Others

    10.4. Market Value Forecast, by Distribution Channel, 2017–2031

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Indication

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Oral Thin Films Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Sublingual Film

        11.2.2. Fast-dissolving Oral Film

        11.2.3. Buccal Film

    11.3. Market Value Forecast, by Indication, 2017–2031

        11.3.1. Pain Management

        11.3.2. Neurological Disorders

        11.3.3. Nausea & Vomiting

        11.3.4. Opioid Dependence

        11.3.5. Others

    11.4. Market Value Forecast, by Distribution Channel, 2017–2031

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Online Pharmacies

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Indication

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region

12. Asia Pacific Oral Thin Films Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Sublingual Film

        12.2.2. Fast-dissolving Oral Film

        12.2.3. Buccal Film

    12.3. Market Value Forecast, by Indication, 2017–2031

        12.3.1. Pain Management

        12.3.2. Neurological Disorders

        12.3.3. Nausea & Vomiting

        12.3.4. Opioid Dependence

        12.3.5. Others

    12.4. Market Value Forecast, by Distribution Channel, 2017–2031

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Online Pharmacies

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Indication

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region

13. Latin America Oral Thin Films Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Sublingual Film

        13.2.2. Fast-dissolving Oral Film

        13.2.3. Buccal Film

    13.3. Market Value Forecast, by Indication, 2017–2031

        13.3.1. Pain Management

        13.3.2. Neurological Disorders

        13.3.3. Nausea & Vomiting

        13.3.4. Opioid Dependence

        13.3.5. Others

    13.4. Market Value Forecast, by Distribution Channel, 2017–2031

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Online Pharmacies

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Indication

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region

14. Middle East & Africa Oral Thin Films Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Sublingual Film

        14.2.2. Fast-dissolving Oral Film

        14.2.3. Buccal Film

    14.3. Market Value Forecast, by Indication, 2017–2031

        14.3.1. Pain Management

        14.3.2. Neurological Disorders

        14.3.3. Nausea & Vomiting

        14.3.4. Opioid Dependence

        14.3.5. Others

    14.4. Market Value Forecast, by Distribution Channel, 2017–2031

        14.4.1. Hospital Pharmacies

        14.4.2. Retail Pharmacies

        14.4.3. Online Pharmacies

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Indication

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2021)

    15.3. Company Profiles

        15.3.1. Aquestive Therapeutics, Inc.

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. C.L. Pharm

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Cure Pharmaceutical

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Dr. Reddy's Laboratories

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Indivior plc

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. IntelGenx Corp.

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Kyu Kyu Pharmaceutical Co., Ltd.

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. DK Livkon Pvt. Ltd.

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. NAL Pharma

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. Seoul Pharma Co., Ltd.

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

        15.3.11. Shilpa Therapeutics Pvt. Ltd.

            15.3.11.1. Company Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Financial Overview

            15.3.11.5. Strategic Overview

        15.3.12. ZIM Laboratories Limited

            15.3.12.1. Company Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Financial Overview

            15.3.12.5. Strategic Overview

        15.3.13. Sunovion Pharmaceuticals Inc.

            15.3.13.1. Company Overview

            15.3.13.2. Product Portfolio

            15.3.13.3. SWOT Analysis

            15.3.13.4. Financial Overview

            15.3.13.5. Strategic Overview

        15.3.14. Other Prominent Players

            15.3.14.1. Company Overview

            15.3.14.2. Product Portfolio

            15.3.14.3. SWOT Analysis

            15.3.14.4. Financial Overview

            15.3.14.5. Strategic Overview

List of Tables

Table 01: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 03: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Oral Thin Films Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 08: North America Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 12: Europe Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 13: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 16: Asia Pacific Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 17: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 20: Latin America Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 21: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 24: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Oral Thin Films Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031

Figure 02: Global Oral Thin Films Market Revenue (US$ Mn), by Product, 2021

Figure 03: Global Oral Thin Films Market Value Share, by Product, 2021

Figure 04: Global Oral Thin Films Market Revenue (US$ Mn), by Indication, 2021

Figure 05: Global Oral Thin Films Market Value Share, by Indication, 2021

Figure 06: Global Oral Thin Films Market Revenue (US$ Mn), by Distribution Channel, 2021

Figure 07: Global Oral Thin Films Market Value Share, by Distribution Channel, 2021

Figure 08: Global Oral Thin Films Market Value Share, by Region, 2021

Figure 09: Global Oral Thin Films Market Value (US$ Mn) Forecast, 2017–2031

Figure 10: Global Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 11: Global Oral Thin Films Market Attractiveness Analysis, by Product, 2022-2031

Figure 12: Global Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 13: Global Oral Thin Films Market Attractiveness Analysis, by Indication, 2022-2031

Figure 14: Global Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 15: Global Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022-2031

Figure 16: Global Oral Thin Films Market Value Share Analysis, by Region, 2017 and 2031

Figure 17: Global Oral Thin Films Market Attractiveness Analysis, by Region, 2022-2031

Figure 18: North America Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 19: North America Oral Thin Films Market Attractiveness Analysis, by Country, 2017–2031

Figure 20: North America Oral Thin Films Market Value Share Analysis, by Country, 2017 and 2031

Figure 21: North America Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 22: North America Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 23: North America Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 24: North America Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031

Figure 25: North America Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031

Figure 26: North America Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 27: Europe Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 29: Europe Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 30: Europe Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 31: Europe Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 32: Europe Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 33: Europe Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031

Figure 34: Europe Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031

Figure 35: Europe Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 36: Asia Pacific Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 37: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 38: Asia Pacific Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 39: Asia Pacific Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 40: Asia Pacific Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 41: Asia Pacific Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 42: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031

Figure 43: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031

Figure 44: Asia Pacific Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 45: Latin America Oral Thin Films Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 46: Latin America Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 47: Latin America Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 48: Latin America Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 49: Latin America Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 50: Latin America Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 51: Latin America Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031

Figure 52: Latin America Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031

Figure 53: Latin America Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 54: Middle East & Africa Oral Thin Films Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 55: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 56: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 57: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Product, 2017 and 2031

Figure 58: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Indication, 2017 and 2031

Figure 59: Middle East & Africa Oral Thin Films Market Value Share Analysis, by Distribution Channel, 2017 and 2031

Figure 60: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Product, 2022–2031

Figure 61: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Indication, 2022–2031

Figure 62: Middle East & Africa Oral Thin Films Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

272

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved